Final answer:
When treating Paranoid Personality Disorder, ethical measures require using the least restrictive restraints only as necessary. Treatment often involves psychotherapy complemented by psychoactive drugs, when indicated, such as antidepressants or antipsychotics.
Step-by-step explanation:
In properly addressing the treatment of Paranoid Personality Disorder (PPD), it's crucial to follow the most ethical and least intrusive procedures. When considering the use of restraints, the approach should always be guided by principles that prioritize patient rights and well-being.
The correct answer is, therefore, to always adhere to the least restrictive measures. This means using restraints only as a last resort when all other interventions have failed and the patient poses a direct threat to themselves or others, and even then, for the shortest duration necessary. Explaining the reasons for restraints to the patient is part of ensuring informed consent and respecting the patient's autonomy.
Psychotherapy is often a component of treating PPD. More pharmacological approaches, like antipsychotics, particularly neuroleptic drugs, can be used to reduce agitation and psychotic symptoms such as hallucinations and delusions.
Other psychoactive drugs, such as antidepressants, anxiolytics, stimulants, and mood stabilizers, are tailored to treat accompanying symptoms or co-occurring disorders that can often present with PPD.
It's essential to individualize treatment plans and consider the full range of therapeutic options, from psychotherapy to medication like selective serotonin reuptake inhibitors, to adequately support individuals with Paranoid Personality Disorder in achieving better mental health outcomes.